Zeo ScientifiX's Total Assets for the quarter that ended in Jan. 2024 was $2,432 Mil.
During the past 12 months, Zeo ScientifiX's average Total Assets Growth Rate was 43423.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 11.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 70.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 67.60% per year.
During the past 13 years, Zeo ScientifiX's highest 3-Year average Total Assets Growth Rate was 212.90%. The lowest was -13.70%. And the median was 54.05%.
The historical data trend for Zeo ScientifiX's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Zeo ScientifiX's Total Assets for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (OTCPK:ZEOX) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Jan. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Zeo ScientifiX's Asset Turnover for the quarter that ended in Jan. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Zeo ScientifiX Total Assets Related Terms
Thank you for viewing the detailed overview of Zeo ScientifiX's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Zeo ScientifiX (Zeo ScientifiX) Business Description
Organicell Regenerative Medicine Inc is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. Its product candidate, Zofinis an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. Zofin is in Phase I/II clinical trials to treat Long COVID and COPD and Osteoarthritis. The company has entered an agreement with CDC to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZEOX has been successfully added to your 